LXR receptor modulators

Details for Australian Patent Application No. 2005251979 (hide)

Owner Laboratoires Fournier S.A.

Inventors Dumas, Christine; Massardier, Christine; Lebreton, Luc; Masson, Philippe; Dodey, Pierre

Agent Spruson & Ferguson

Pub. Number AU-B-2005251979

PCT Pub. Number WO2005/121093

Priority 04 04958 07.05.04 FR

Filing date 9 May 2005

Wipo publication date 22 December 2005

Acceptance publication date 12 April 2012

International Classifications

C07D 215/58 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/121093 Priority application(s): WO2005/121093

12 April 2012 Application Accepted

  Published as AU-B-2005251979

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251982-2H or 3H-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof

2005251977-5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents